Ocrevus (ocrelizumab) delayed disability progression and worsening hand function among a large group of people with primary progressive multiple sclerosis (PPMS), including those who were older and had more advanced disease. The data, which come from the Phase 3 ORATORIO-HAND trial (NCT04035005), were presented by Jiwon Oh,…
Discussion
When I began this column about living with multiple sclerosis (MS) nearly four years ago, I worried about sharing good things in my life and about comparing my situation with that of others. It made me feel guilty. After writing about it, though, the feedback I received from…
Discussion
If I sit for over three minutes, it takes almost that long to regain movement in my legs when I stand. Even then, my limbs must fight the relentless pressure of immobility. Focused therapies, such as the Portable Neuromodulation Stimulator, have given me back years of lost function.
Discussion
The experimental drug fenebrutinib was shown to significantly outperform Aubagio (teriflunomide), an approved therapy, in reducing relapses and MRI markers of disease activity in people with relapsing forms of multiple sclerosis (MS). That’s according to new data from a pair of largely identical Phase 3 clinical trials…
Discussion
A team of scientists in China, attempting to understand the function of a genetic mutation commonly found in animals living at high altitudes, discovered a previously unknown mechanism key to myelin repair. The discovery could have important implications for diseases such as multiple sclerosis (MS), which is marked…
Get regular updates to your inbox.
